Pharmacies in England will be able to prescribe medicines for seven common conditions without a GP prescription under new proposals intended to relieve the pressure on pri
The UK’s voluntary system of revenue rebates to limit rises in medicines spending is already causing deep upset among branded drug manufacturers as clawbacks rise.
The US Supreme Court has said it will allow the abortion pill mifepristone to remain available while an appeal of the decision to strike down its regulatory approval make
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.